Eribulin liposomal

Drug Profile

Eribulin liposomal

Alternative Names: E7389 liposomal; E7389-LF; Liposomal eribulin

Latest Information Update: 12 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eisai Inc
  • Class 2 ring heterocyclic compounds; Antineoplastics; Cyclic ethers; Furans; Ketones; Macrocyclic compounds; Small molecules
  • Mechanism of Action Apoptosis stimulants; Cadherin modulators; Receptor protein-tyrosine kinase modulators; Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Solid tumours

Most Recent Events

  • 12 Feb 2018 Eribulin liposomal is still in phase I trials for Solid tumours in United Kingdom (Eisai pipeline, February 2018)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Solid-tumours in United Kingdom (IV, Infusion)
  • 01 Sep 2017 Phase-I clinical trials in Solid tumours (Late-stage disease, Recurrent, Inoperable/Unresectable) in Japan (IV) (JapicCTI-173649)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top